Tuesday, Oct 28, 2025
1:30pm - 3:30pm
Lecture by:
Quincy Almeida
This lecture will be on the early identification of neurodegenerative disorders, with a specific focus on Parkinson’s disease and dementia. Our discussion today will delve into the intricacies of these conditions, their early signs, and the paramount importance of prompt diagnosis and intervention. Each neurodegenerative condition presents unique challenges and impacts not only individuals, but their families and society.
In this lecture, we will explore the latest advancements and techniques in the early identification of Parkinson’s disease and dementia. From innovative diagnostic tools and biomarkers to cutting-edge imaging techniques and genetic testing, our journey will cover the spectrum of current research on understanding the underlying mechanisms and clinical practices aimed at combating these debilitating disorders.
Dr. Quincy Almeida, is a world-renowned Parkinson’s and neurodegenerative disease expert with a double Ph.D in Behavioral Neuroscience and Kinesiology. As a Full Professor, Dr. Almeida founded the internationally-recognized Movement Disorders Research & Rehabilitation Centre, has won several awards including the Polanyi Prize for Physiology and Medicine, the Queen’s Elizabeth II Diamond Jubilee medal, the Franklin Henry Young Scientist Award for Motor Control, and North American Society for the Psychology of Sport and Physical Activity Early Career Distinguished Scholar Awards.
With over 100 peer-reviewed publications in journals such a Lancet Neurology, Movement Disorders, and Neurorehabilitation & Neural Repair, Dr. Almeida focuses on underlying mechanisms of neurodegeneration and then translating them into therapeutic interventions for those living with neurodegenerative conditions such as Parkinson’s disease or dementia, such as the popular and evidence-based SAFEx exercise programs to slow the progression of neurodegenerative disease.
His research has been funded by the Canada Foundation for Innovation, Canadian Institutes for Health Research, the Michael J. Fox Foundation, and the National Institute of Health in the United States. Dr. Almeida was also a site leader for the Canadian Consortium for Neurodegeneration and Aging SYNERGIC trial and COMPASS-ND, which focuses on memory, cognitive and movement disorders. Dr. Almeida brings access to an integrated health care team of specialists, as well as some of the most innovative assistive devices, inventions and novel therapeutics for the management of motor, cognitive and pain disorders.
Third Age Learning Kitchener Waterloo